HOME >> MEDICINE >> NEWS
Simpler blood thinning medication effective for preventing blood clots and stroke

CHICAGO - A medication that could simplify anticoagulation therapy, ximelagatran, was found to be as effective as other common therapies for preventing stroke and recurrent blood clots, according to studies in the February 9 issue of JAMA. Ximelagatran is currently approved for use in some European countries but it has not been approved in the United States because of concerns about adverse effects.

In the first study, Jean-Noel Fiessinger, M.D., of Hpital Europen Georges Pompidou, Paris, and colleagues conducted a study of patients with deep vein thrombosis (blood clot in veins of the legs, pelvis or arms) to determine the efficacy and safety of oral ximelagatran compared to standard treatment with the anticoagulants enoxaparin and warfarin.

According to background information in the article, current therapy for patients with acute venous thromboembolism consists of 5 to 7 days of the anticoagulant heparin overlapped with and followed by long-term, oral anticoagulation with a therapy such as warfarin. Heparin must be given parenterally (by injection, usually through the veins) and administration requires considerable health care resources. Warfarin is given orally, but has an unpredictable dose response, interacts with many drugs, and can be affected by changes in diet; thus, continued coagulation monitoring and dose adjustment are necessary. Ximelagatran is administered orally and is rapidly absorbed and quickly converted to its active form.

The trial (Thrombin Inhibitor in Venous Thromboembolism [THRIVE] Treatment Study) included 2,489 patients with deep vein thrombosis. The study was conducted at 279 centers in 28 countries from September 2000 through December 2002. Patients were randomized to receive 6 months of treatment with either oral ximelagatran, twice daily, or subcutaneous enoxaparin, twice daily for 5 to 20 days followed by warfarin.

The researchers found that the primary efficacy end point of recurrent venous thromboe
'"/>

Contact: Bruce L. Davidson, M.D.
206-215-2500
JAMA and Archives Journals
8-Feb-2005


Page: 1 2 3 4 5

Related medicine news :

1. Simpler alphabet guidelines for treating acute coronary syndrome reduce risk
2. Simpler, cheaper way to make and fit prosthetics developed
3. Progress In Cancer-Vaccine Studies: Simpler, Safer Approach Producing Encouraging Results
4. A marker for new blood vessel formation in tumors
5. Acupuncture found to lower elevations in blood pressure
6. Diagnostic test for range of blood disorders on the horizon
7. Research suggests possible blood test for multiple sclerosis
8. Epstein-Barr virus protein crucial to its role in blood cancers
9. Simple blood test may help to predict cardiovascular risk in older women
10. Drug that hinders blood vessel growth under study in ovarian cancer
11. Laughter helps blood vessels function better

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... ... are joining biomedical engineers from Carnegie Mellon University (CMU) to develop a new ... who have undergone open heart surgery. , The AGH/CMU team was recently awarded ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth solution, ... their virtual practice in under 90 seconds. , According to the U.S. ...
(Date:8/31/2020)... ... , ... In an effort to give back to the community in which ... hotel room booked with a special new rate code to benefit children and families ... immediately. Donations will be applied to any room type, any time, now through ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... designed to help treat patients with respiratory conditions, including COVID-19, while reducing the ... and oxygen, but it captures exhaled gas and scrubs it free of carbon ...
(Date:8/28/2020)... ... 28, 2020 , ... A July 27 article ... at an increased risk of developing severe COVID-19 symptoms. The article does not ... the same organ systems that the coronavirus attacks are already suffering from the ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, M.D., ... the University of Rochester Medical Center, in Upstate New York. She completed a ... clinical faculty from the Harvard and Yale Departments of Dermatology and is one ...
(Date:9/1/2020)... ... September 01, 2020 , ... While coronavirus cases continue to increase across ... and community organizations remain closed. Because about 80% of blood donations are made at ... blood donors and blood drive hosts to ensure blood products are readily available for ...
(Date:9/1/2020)... ... September 01, 2020 , ... September is National Ovarian Cancer Awareness ... deaths than any other cancer of the female reproductive system. The American Cancer ... and about 14,000 women will die from this disease. Throughout the month of ...
Breaking Medicine Technology:
Cached News: